| scholarly article | Q13442814 |
| P50 | author | Michael J Sikorski | Q86635785 |
| Peter Kofinas | Q44542374 | ||
| P2093 | author name string | Adam M Behrens | |
| P2860 | cites work | A novel gelatin sponge for accelerated hemostasis | Q84476813 |
| A reversible wet/dry adhesive inspired by mussels and geckos | Q28236935 | ||
| Platelet receptors for collagen | Q28241992 | ||
| Role of tissue factor in hemostasis, thrombosis, and vascular development | Q28259220 | ||
| Injectable citrate-based mussel-inspired tissue bioadhesives with high wet strength for sutureless wound closure | Q30416501 | ||
| Hemostats, sealants, and adhesives: components of the surgical toolbox | Q30446024 | ||
| Fibrin sealant: past, present, and future: a brief review | Q30449208 | ||
| Hemostats, sealants, and adhesives: a practical guide for the surgeon | Q30456352 | ||
| Preparation and characterization of a photocrosslinkable bioadhesive inspired by marine mussel | Q30585779 | ||
| Concentrated albumin as a biological glue for hemorrhage control on hepatic resection with argon beam coagulation | Q31112258 | ||
| Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex | Q31974821 | ||
| Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: molecular and formulation parameters vs. cell proliferation potential | Q33222489 | ||
| Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets | Q33314508 | ||
| Fibrinogen-conjugated albumin polymers and their interaction with platelets under flow conditions | Q33340486 | ||
| Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia | Q33365111 | ||
| Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo | Q33367016 | ||
| Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute | Q33382776 | ||
| Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation | Q33386421 | ||
| A liposome based platelet substitute, the plateletsome, with hemostatic efficacy | Q33493616 | ||
| Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 | ||
| Collagen-platelet interaction: platelet non-integrin receptors | Q33599344 | ||
| Polyphosphate as a general procoagulant agent | Q33724794 | ||
| Biodegradable block poly(ester-urethane)s based on poly(3-hydroxybutyrate-co-4-hydroxybutyrate) copolymers | Q33817749 | ||
| The plasminogen activator/plasmin system | Q34202297 | ||
| Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. | Q34202431 | ||
| Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion | Q34226667 | ||
| Chemical properties of catechols and their molecular modes of toxic action in cells, from microorganisms to mammals | Q34231053 | ||
| Polyphosphate exerts differential effects on blood clotting, depending on polymer size. | Q34360392 | ||
| Effect of aprotinin on need for blood transfusion after repeat open-heart surgery | Q34399916 | ||
| Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis | Q34635642 | ||
| Intravenous hemostat: nanotechnology to halt bleeding. | Q41470605 | ||
| In vitro analysis of polyurethane foam as a topical hemostatic agent | Q42267309 | ||
| Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma | Q42579276 | ||
| BioGlue in 2011: what is its role in cardiac surgery? | Q43050994 | ||
| Polylactide stereocomplex-based electrospun materials possessing surface with antibacterial and hemostatic properties. | Q43233693 | ||
| Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine | Q43298272 | ||
| Epidemiology of traumatic deaths: comprehensive population-based assessment. | Q43691709 | ||
| Novel wound sealants: biomaterials and applications. | Q43879817 | ||
| Novel keratin (KeraStat™) and polyurethane (Nanosan(R)-Sorb) biomaterials are hemostatic in a porcine lethal extremity hemorrhage model. | Q43909297 | ||
| Blood protein adsorption onto chitosan | Q44008294 | ||
| Zeolite/polymer composite hollow microspheres containing antibiotics and the in vitro drug release | Q44725129 | ||
| In situ polymerizable polyethyleneglycol containing polyesterpolyol acrylates for tissue sealant applications | Q44774201 | ||
| Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage | Q44931496 | ||
| The potential of poly(N-isopropylacrylamide) (PNIPAM)-grafted hyaluronan and PNIPAM-grafted gelatin in the control of post-surgical tissue adhesions | Q44999118 | ||
| In vitro and in vivo evaluation of polymer hydrogels for hemorrhage control | Q45029256 | ||
| The safety of fibrin sealants | Q45095482 | ||
| Self-gelling hydrogels based on oppositely charged dextran microspheres | Q45171274 | ||
| A keratin biomaterial gel hemostat derived from human hair: evaluation in a rabbit model of lethal liver injury | Q45342216 | ||
| Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group | Q45874565 | ||
| A mechanistic investigation of the effect of keratin-based hemostatic agents on coagulation. | Q45922082 | ||
| The development of photochemically crosslinked native fibrinogen as a rapidly formed and mechanically strong surgical tissue sealant. | Q46161048 | ||
| Spherical bioactive glass with enhanced rates of hydroxyapatite deposition and hemostatic activity | Q46216969 | ||
| Metal oxide surface charge mediated hemostasis | Q46277929 | ||
| Experimental optimization of an in situ forming hydrogel for hemorrhage control | Q46382198 | ||
| Development of a recombinant human collagen-type III based hemostat | Q46969574 | ||
| Effect of chitosan molecular weight and deacetylation degree on hemostasis | Q47287342 | ||
| Structural design of the dry fibrin sealant dressing and its impact on the hemostatic efficacy of the product | Q47336115 | ||
| Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties | Q47396251 | ||
| In vivo efficacy of a new autologous fibrin sealant | Q47908626 | ||
| An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuikClot | Q47965904 | ||
| Comparative efficacy of granular and bagged formulations of the hemostatic agent QuikClot | Q48019403 | ||
| A biodegradable and biocompatible gecko-inspired tissue adhesive | Q34752203 | ||
| The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients | Q34817997 | ||
| A profile of combat injury | Q35136408 | ||
| Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 | ||
| Safety profile of recombinant factor VIIa | Q35661521 | ||
| Quinone chemistry and melanogenesis | Q35707913 | ||
| The use of local agents: bone wax, gelatin, collagen, oxidized cellulose | Q35819636 | ||
| Hemostatic dressings for the first responder: a review | Q35923773 | ||
| Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma | Q36284647 | ||
| Clinical benefits and risk analysis of topical hemostats: a review | Q36290648 | ||
| Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes. | Q36521995 | ||
| Prevention and treatment of major blood loss | Q36835345 | ||
| Polyphosphate enhances fibrin clot structure | Q36915892 | ||
| Mechanically robust, negative-swelling, mussel-inspired tissue adhesives | Q36937034 | ||
| Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis | Q37146797 | ||
| New hemostatic agents in the combat setting | Q37642898 | ||
| Complications of recombinant activated human coagulation factor VII. | Q37647123 | ||
| A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. | Q37654250 | ||
| Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008). | Q37693198 | ||
| Decreasing killed in action and died of wounds rates in combat wounded | Q37771830 | ||
| Pre-hospital haemostatic dressings: a systematic review | Q37805048 | ||
| Military applications of novel hemostatic devices | Q37820974 | ||
| Comparison of Celox-A, ChitoFlex, WoundStat, and combat gauze hemostatic agents versus standard gauze dressing in control of hemorrhage in a swine model of penetrating trauma | Q37865589 | ||
| Platelets at work in primary hemostasis. | Q37865759 | ||
| Management of haemostasis in surgery: sealant and glue applications | Q38021554 | ||
| Analysis of the causes of death of casualties in field military setting | Q38048322 | ||
| Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients | Q39113624 | ||
| Flexible and microporous chitosan hydrogel/nano ZnO composite bandages for wound dressing: in vitro and in vivo evaluation | Q39366958 | ||
| Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in Swine | Q39379993 | ||
| The use of native chemical functional groups presented by wound beds for the covalent attachment of polymeric microcarriers of bioactive factors | Q39532683 | ||
| Topical hemostatic agents for dermatologic surgery | Q39642681 | ||
| Molecular imprinted macroporous chitosan coated mesoporous silica xerogels for hemorrhage control | Q39676287 | ||
| Blood clot initiation by mesocellular foams: dependence on nanopore size and enzyme immobilization. | Q39909283 | ||
| Nano hemostat solution: immediate hemostasis at the nanoscale. | Q40243410 | ||
| Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity | Q40430469 | ||
| Strategies for the avoidance of bacterial contamination of blood components | Q40720704 | ||
| Intravenous hemostatic nanoparticles increase survival following blunt trauma injury | Q41215308 | ||
| Biomimetic sealant based on gelatin and microbial transglutaminase: an initial in vivo investigation | Q48021505 | ||
| Microporous polysaccharide hemospheres for management of laparoscopic trocar injury to the spleen | Q48032667 | ||
| Hemostatic properties and the role of cell receptor recognition in human hair keratin protein hydrogels. | Q48534250 | ||
| A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action | Q48917408 | ||
| Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor | Q50132660 | ||
| A novel synthetic tissue-adhesive hydrogel using a crosslinkable polymeric micelle. | Q51125410 | ||
| Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. | Q51299797 | ||
| Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine. | Q51372731 | ||
| Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. | Q51607720 | ||
| Thermal injury resulting from application of a granular mineral hemostatic agent. | Q51623581 | ||
| Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes. | Q51759013 | ||
| Biocompatibility and osseointegration of reconstituted keratin in an ovine model. | Q51824808 | ||
| Blood-aggregating hydrogel particles for use as a hemostatic agent. | Q53309997 | ||
| Evaluation of photo-crosslinked fibrinogen as a rapid and strong tissue adhesive. | Q53343703 | ||
| A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. | Q53369345 | ||
| Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials. | Q53424238 | ||
| FVII dependent coagulation activation in citrated plasma by polymer hydrogels. | Q53451808 | ||
| Hemostatic efficacy of biological self-assembling peptide nanofibers in a rat kidney model. | Q53498851 | ||
| Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control. | Q54401384 | ||
| Treatment of traumatic bleeding with recombinant factor VIIa. | Q55033461 | ||
| Injury Severity and Causes of Death From Operation Iraqi Freedom and Operation Enduring Freedom: 2003???2004 Versus 2006 | Q56807533 | ||
| Keratin-hydroxyapatite composites: Biocompatibility, osseointegration, and physical properties in an ovine model | Q56934680 | ||
| Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin hydrogel surfaces: interrelationship between microscopic structure and mechanical property of surface regions and cell adhesiveness | Q57350075 | ||
| Polymers for the rapid and effective activation and aggregation of platelets | Q57355665 | ||
| Studies on the mechanism of the antifibrinolytic action of tranexamic acid | Q70658647 | ||
| Low-dose and high-dose aprotinin improve hemostasis in coronary operations | Q71379767 | ||
| Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents | Q71671478 | ||
| Use of chitosan as a biomaterial: studies on its safety and hemostatic potential | Q71934660 | ||
| Efficacy of a fibrin hemostatic bandage in controlling hemorrhage from experimental arterial injuries | Q72141614 | ||
| Chitosan: A New Hemostatic | Q72787105 | ||
| Comparative analysis of hemostatic agents in a swine model of lethal groin injury | Q73544142 | ||
| Frozen platelets and platelet substitutes in transfusion medicine | Q73656652 | ||
| Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions | Q73886909 | ||
| Potential uses of absorbable fibrin adhesive bandage for genitourinary trauma | Q77443942 | ||
| Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid), and carbodiimide | Q77741970 | ||
| Effect of additives on gelation and tissue adhesion of gelatin-poly(L-glutamic acid) mixture | Q77780341 | ||
| Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis | Q77781951 | ||
| Local hemostasis during laparoscopic partial nephrectomy using biodegradable hydrogels: initial porcine results | Q78417008 | ||
| A case series describing thermal injury resulting from zeolite use for hemorrhage control in combat operations | Q79434101 | ||
| The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose | Q79713070 | ||
| Tuning of the surface biological behavior of poly(L-lactide)-based electrospun materials by polyelectrolyte complex formation | Q82440761 | ||
| A novel hemostatic delivery device for thrombin: Biodegradable poly(D,L‐lactide‐co‐glycolide) 50:50 microspheres | Q82592410 | ||
| Hemostatic multilayer coatings | Q83186708 | ||
| Sealing effects of cross-linked gelatin | Q83319232 | ||
| Development of in situ-forming hydrogels for hemorrhage control | Q83612026 | ||
| In vivo and in vitro evaluation of gelation and hemostatic properties of a novel tissue-adhesive hydrogel containing a cross-linkable polymeric micelle | Q83707678 | ||
| Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro | Q83790128 | ||
| Rapidly curable chitosan-PEG hydrogels as tissue adhesives for hemostasis and wound healing | Q84196196 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 4182-4194 | |
| P577 | publication date | 2013-12-12 | |
| P1433 | published in | Journal of Biomedical Materials Research Part A | Q15749234 |
| P1476 | title | Hemostatic strategies for traumatic and surgical bleeding | |
| P478 | volume | 102 |
| Q48044077 | Comparative Evaluation of Biological Performance, Biosecurity, and Availability of Cellulose-Based Absorbable Hemostats. |
| Q64265776 | Cuboidal tethered cyclodextrin frameworks tailored for hemostasis and injured vessel targeting |
| Q47580678 | Design and development of polysaccharide hemostatic materials and their hemostatic mechanism |
| Q56365154 | Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels |
| Q92163639 | Fabrication and Characterization of Low Methoxyl Pectin/Gelatin/Carboxymethyl Cellulose Absorbent Hydrogel Film for Wound Dressing Applications |
| Q90626727 | Hemostatic agents for prehospital hemorrhage control: a narrative review |
| Q92896184 | Improving the adhesion, flexibility, and hemostatic efficacy of a sprayable polymer blend surgical sealant by incorporating silica particles |
| Q99407020 | Recent Advances on Synthetic and Polysaccharide Adhesives for Biological Hemostatic Applications |
| Q55510284 | Study of locust bean gum reinforced cyst-chitosan and oxidized dextran based semi-IPN cryogel dressing for hemostatic application. |
| Q47716200 | Superhydrophobic/Superhydrophilic Janus Fabrics Reducing Blood Loss. |
| Q47751733 | Zeolite-loaded alginate-chitosan hydrogel beads as a topical hemostat |
Search more.